https://worksinprogress.co/issue/the-future-of-kidney-treatment/
SGLT2 Inhibitors (Flozins): How One Drug Treats Three Diseases
Jun 13, 2026 - SGLT2 inhibitors (flozins) cut cardiovascular deaths 38% and slow kidney disease. They were only supposed to treat diabetes. Why do they work so well?
inhibitorsonedrugtreatsthree